Jian Pang

1.3k total citations
34 papers, 700 citations indexed

About

Jian Pang is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jian Pang has authored 34 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jian Pang's work include Cancer Immunotherapy and Biomarkers (8 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers) and Cancer Risks and Factors (4 papers). Jian Pang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers) and Cancer Risks and Factors (4 papers). Jian Pang collaborates with scholars based in China, United States and Sweden. Jian Pang's co-authors include Yiqiang Huang, Luofu Wang, Jun Jiang, Weihua Lan, Dianzheng Zhang, Dali Tong, Qiuli Liu, Gaolei Liu, Lin-ang Wang and Xingxia Yang and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Jian Pang

33 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jian Pang China 15 341 194 182 132 104 34 700
Qiongyu Hao United States 15 424 1.2× 220 1.1× 218 1.2× 153 1.2× 81 0.8× 28 789
Ting Huang China 18 421 1.2× 257 1.3× 178 1.0× 127 1.0× 134 1.3× 40 900
Katarzyna Kulcenty Poland 17 377 1.1× 156 0.8× 192 1.1× 92 0.7× 67 0.6× 48 766
Maryam Rezaei Iran 19 450 1.3× 261 1.3× 137 0.8× 96 0.7× 63 0.6× 52 840
Yukiko Nishiguchi Japan 20 401 1.2× 236 1.2× 208 1.1× 82 0.6× 146 1.4× 45 837
Remya Raja India 15 361 1.1× 175 0.9× 161 0.9× 120 0.9× 64 0.6× 29 807
Haiyan He China 13 402 1.2× 217 1.1× 123 0.7× 148 1.1× 48 0.5× 34 724
María F. Mercogliano Argentina 15 326 1.0× 170 0.9× 344 1.9× 169 1.3× 53 0.5× 23 793

Countries citing papers authored by Jian Pang

Since Specialization
Citations

This map shows the geographic impact of Jian Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Pang more than expected).

Fields of papers citing papers by Jian Pang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Pang. The network helps show where Jian Pang may publish in the future.

Co-authorship network of co-authors of Jian Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Jian Pang. A scholar is included among the top collaborators of Jian Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian Pang. Jian Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Sheng, et al.. (2025). Baicalin inhibits conjugative transfer of multidrug-resistant plasmid RP4 by regulating autoinducer-2 transporter protein LsrB. Ecotoxicology and Environmental Safety. 298. 118334–118334. 1 indexed citations
2.
Pang, Jian, et al.. (2024). Systemic immune-inflammation index as a prognostic marker in HER2-positive breast cancer patients undergoing trastuzumab therapy. Scientific Reports. 14(1). 6578–6578. 10 indexed citations
3.
Ding, Nianhua, Jian Pang, Xuan Liu, et al.. (2024). Prognostic value of baseline neutrophil/lymphocyte ratio in HER2-positive metastatic breast cancer: exploratory analysis of data from the CLEOPATRA trial. Breast Cancer Research. 26(1). 9–9. 3 indexed citations
4.
5.
Pang, Jian, Nianhua Ding, Xuan Liu, et al.. (2024). Prognostic Value of the Baseline Systemic Immune-Inflammation Index in HER2-Positive Metastatic Breast Cancer: Exploratory Analysis of Two Prospective Trials. Annals of Surgical Oncology. 32(2). 750–759. 37 indexed citations
6.
Zhu, Jinfeng, Qitong Chen, Liyun Zeng, et al.. (2023). Multi-omics analysis reveals the involvement of origin recognition complex subunit 6 in tumor immune regulation and malignant progression. Frontiers in Immunology. 14. 1236806–1236806.
7.
Pang, Jian, Haiyan Zhou, Xue Dong, Shouman Wang, & Zhi Xiao. (2021). Relationship Between the Neutrophil to Lymphocyte Ratio, Stromal Tumor-infiltrating Lymphocytes, and the Prognosis and Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer. Clinical Breast Cancer. 21(6). e681–e687. 13 indexed citations
8.
Zhang, Kejing, Lili Tang, Yuan Yang, et al.. (2021). Association Between Single-Nucleotide Polymorphisms in Breast Cancer Susceptibility Genes and Clinicopathological Characteristics. Clinical Epidemiology. Volume 13. 103–112. 4 indexed citations
9.
10.
Liu, Qiuli, Jian Pang, Jing Xu, et al.. (2020). Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2. The Journal of Pathology. 253(1). 106–118. 48 indexed citations
11.
Tang, Tang, Jian Pang, Jing Xu, et al.. (2020). LSD1 Promotes Bladder Cancer Progression by Upregulating LEF1 and Enhancing EMT. Frontiers in Oncology. 10. 1234–1234. 34 indexed citations
12.
Liu, Qiuli, Dali Tong, Gaolei Liu, et al.. (2018). Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration. Clinical Cancer Research. 24(22). 5622–5634. 86 indexed citations
13.
Tong, Dali, Qiuli Liu, Lin-ang Wang, et al.. (2018). The roles of the COX2/PGE2/EP axis in therapeutic resistance. Cancer and Metastasis Reviews. 37(2-3). 355–368. 84 indexed citations
14.
15.
Pang, Jian, Qingsong Zhou, Xiao‐Feng Sun, et al.. (2017). Effect of low-dose zearalenone exposure on reproductive capacity of male mice. Toxicology and Applied Pharmacology. 333. 60–67. 36 indexed citations
16.
Chen, Xiangmeng, et al.. (2016). Addison's disease due to adrenal tuberculosis diagnosed by 18F-FDG PET/CT: one case report. 36(1). 85–87. 1 indexed citations
17.
Zhao, Yongfang, et al.. (2015). Bufalin Inhibits the Differentiation and Proliferation of Cancer Stem Cells Derived from Primary Osteosarcoma Cells through Mir-148a. Cellular Physiology and Biochemistry. 36(3). 1186–1196. 45 indexed citations
18.
Gao, Jingchun, Yi Zhao, Bing Wei, et al.. (2013). Mirk/Dyrk1B mediates G0/G1 to S phase cell cycle progression and cell survival involving MAPK/ERK signaling in human cancer cells. Cancer Cell International. 13(1). 2–2. 43 indexed citations
19.
Lü, Jian, Junhang Luo, Jian Pang, et al.. (2012). Lentivirus-mediated RNA interference of clusterin enhances the chemosensitivity of EJ bladder cancer cells to epirubicin in vitro. Molecular Medicine Reports. 6(5). 1133–1139. 8 indexed citations
20.
Zhao, Qihong, Jian Pang, Kim W. McIntyre, et al.. (2009). A CCR2/CCR5-dual antagonist, BMS-A, offers a potential novel oral therapy for the treatment of autoimmune disease (92.6). The Journal of Immunology. 182(Supplement_1). 92.6–92.6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qiongyu Hao Breakdown of academic impact, for papers by Ting Huang Breakdown of academic impact, for papers by Katarzyna Kulcenty Breakdown of academic impact, for papers by Maryam Rezaei Breakdown of academic impact, for papers by Yukiko Nishiguchi Breakdown of academic impact, for papers by Remya Raja Breakdown of academic impact, for papers by Haiyan He Breakdown of academic impact, for papers by María F. Mercogliano
Rankless by CCL
2026